PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

Ann: Paradigm Receives $7.36m R&D Tax Incentive Refund, page-7

  1. 7,601 Posts.
    lightbulb Created with Sketch. 6870
    Wasn't guidance $8-11m?

    "Forecast cash outflow for the March 2024 quarter is expected to be $8 - $11m (including R&D refund) and the June 2024 quarter expected to be in the $6m - $8m range which is inclusive of phase 3 stage 2 restart costs." (December qtrly)

    Hopefully the final upfront cash flows with trials reiterated in the recent quarterly flowing out early in the quarter and nothing more....
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢
Change
0.005(2.17%)
Mkt cap ! $82.20M
Open High Low Value Volume
23.5¢ 23.5¢ 23.0¢ $85.35K 365.1K

Buyers (Bids)

No. Vol. Price($)
10 280011 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 44703 3
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.